n-3 Fatty Acids Cut Nonesterified Fatty Acid, T2DM Link

This article originally appeared here.
Share this content:
n-3 Fatty Acids Cut Nonesterified Fatty Acid, T2DM Link
n-3 Fatty Acids Cut Nonesterified Fatty Acid, T2DM Link

MONDAY, Jan. 19, 2015 (HealthDay News) -- Nonesterified fatty acids (NEFAs) are associated with type 2 diabetes, and the association is modified by n-3 FA levels, according to a study published online Jan. 8 in Diabetes Care.

Brian T. Steffen, Ph.D., from the University of Minnesota in Minneapolis, and colleagues examined whether serum levels of NEFAs relate to the risk of incident type 2 diabetes, and whether plasma n-3 FAs modify this correlation. The authors measured NEFAs in fasting serum in 5,697 participants of the Multi-Ethnic Study of Atherosclerosis, and determined phospholipid n-3 FAs eicosapentaenoic and docosahexaenoic acids in plasma.

The researchers identified higher diabetes incidence across successive NEFA quartiles over a mean 11.4-year study period (Ptrend < 0.001). There was a significant interaction noted between n-3 FAs and the association between NEFAs and type 2 diabetes (Pinteraction = 0.03). A higher risk of type 2 diabetes was seen across quartiles of NEFAs (Ptrend < 0.001) among individuals with lower n-3 levels (<75th percentile). For participants with n-3 FAs ≥75th percentile, no significant associations were seen (Ptrend = 0.54).

"NEFAs are a marker of type 2 diabetes and may have clinical utility for detecting risk of its development," the authors write. "The modifying influence of n-3 FAs suggests a protective effect against disease and/or metabolic dysfunction related to NEFAs and requires further study."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »